BioSpace News Archive

Deals

Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced the exercise of 712,500 warrants from its June 2020 financing for net proceeds to the company of $1,425,000.

February 26, 2021

·

4 min read

Canada to receive 2 million doses of AstraZeneca’s COVID-19 vaccine manufactured by the Serum Institute of India

The Government of Canada is taking steps to ensure more people in Canada are vaccinated more quickly, and continues to work to give Canadians access to safe and effective COVID-19 vaccines as soon as possible

February 26, 2021

·

3 min read

BioCapital

FDA Authorizes Marketing of Novel Device to Help Protect Athletes’ Brains During Head Impacts

Today, the U.S. Food and Drug Administration authorized marketing of a new device intended to be worn around the neck of athletes aged 13 years and older during sports activities to aid in the protection of the brain from the effects associated with repetitive sub-concussive head impacts.

February 26, 2021

·

5 min read

BioMidwest

MatMaCorp’s COVID-19 2SF RNA Test Effective in Detecting Variants

MatMaCorp (Materials and Machines Corporation), a developer of comprehensive molecular diagnostic systems, today announced data demonstrating the effectiveness of the company’s COVID-19 2SF RNA test in detecting variants associated with SARS-CoV-2, the virus causing COVID-19.

February 26, 2021

·

3 min read

Chimerix, Exclusive Worldwide Licensee of Cantex’s Investigational Product, DSTAT, Has Announced Promising Topline Results from the First Cohort of a Randomized COVID-19 Clinical Trial

Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for the treatment of inflammatory lung diseases and cancer, today announced that Chimerix, Inc. (NASDAQ:CMRX)

February 26, 2021

·

2 min read

Deals

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive Dr. Daniel R. Karlin and former Google AI/ML industry veteran Bradford Cross added to MindMed executive team

February 26, 2021

·

7 min read

BioCapital

Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, announced that it will host a Town Hall at 1 P.M., Eastern Time on Thursday, March 18, 2021.

February 26, 2021

·

4 min read

Biotech Beach

PhaseBio Pharmaceuticals to Participate in Upcoming Investor Conferences

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that the company will be participating in two upcoming virtual investor conferences.

February 26, 2021

·

2 min read

BioCapital

NextCure to Host Virtual R&D Update Event on March 4, 2021

NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, announced that it will host a Virtual R&D Update Event at 5:00 p.m. ET on Thursday, March 4.

February 26, 2021

·

3 min read

BioCapital

GlycoMimetics to Present at Three Upcoming Virtual Healthcare Investor Conferences

GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that executives from the Company plan to participate in three virtual healthcare conferences in March.

February 26, 2021

·

2 min read